Cargando…

CORRIGENDUM: Utility of (99 m)Tc-Pyrophosphate Scintigraphy in Diagnosing Transthyretin Cardiac Amyloidosis in Real-World Practice

Detalles Bibliográficos
Autores principales:	Tsutsui, Yoshitomo, Kubota, Toru, Kato, Seiya, Nozoe, Masatsugu, Suematsu, Nobuhiro, Okabe, Masanori, Yamamoto, Yusuke, Tsutsui, Hiroyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Circulation Society 2019
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897971/ https://www.ncbi.nlm.nih.gov/pubmed/33704267 http://dx.doi.org/10.1253/circrep.CR-66-0005

Ejemplares similares

Utility of (99 m)Tc-Pyrophosphate Scintigraphy in Diagnosing Transthyretin Cardiac Amyloidosis in Real-World Practice
por: Tsutsui, Yoshitomo, et al.
Publicado: (2019)

Successful bipolar ablation for ventricular tachycardia with potential substrate identification by pre-procedural cardiac magnetic resonance imaging
por: Sakamoto, Kazuo, et al.
Publicado: (2017)

(99m)Technetium‐pyrophosphate scintigraphy: a practical guide for early diagnosis of transthyretin amyloid cardiomyopathy
por: Tahara, Nobuhiro, et al.
Publicado: (2021)

Comparison of 1-h with 3-h planar (99m)Tc-pyrophosphate scintigraphy in patients with suspected transthyretin cardiac amyloidosis using SPECT as a reference standard
por: Saitou, Toshinori, et al.
Publicado: (2022)

Extracardiac Accumulation of Technetium-99m-Pyrophosphate in Transthyretin Cardiac Amyloidosis
por: Takahashi, Koji, et al.
Publicado: (2021)

An optimized imaging protocol for [(99m)Tc]Tc-DPD scintigraphy and SPECT/CT quantification in cardiac transthyretin (ATTR) amyloidosis
por: Schatka, Imke, et al.
Publicado: (2021)

Microcalcification and (99m)Tc-Pyrophosphate Uptake without Increased Bone Metabolism in Cardiac Tissue from Patients with Transthyretin Cardiac Amyloidosis
por: Mori, Atsushi, et al.
Publicado: (2023)

Radiopharmaceutical supply disruptions and the use of (99m)Tc-hydroxymethylene diphosphonate as an alternative to (99m)Tc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: An ASNC Information Statement
por: Miller, Edward J., et al.
Publicado: (2022)

Usefulness of quantitative (99m)Tc-pyrophosphate SPECT/CT for predicting the prognosis of patients with wild-type transthyretin cardiac amyloidosis
por: Ogasawara, Kouji, et al.
Publicado: (2022)

Volumetric evaluation of (99m)Tc-pyrophosphate SPECT/CT for transthyretin cardiac amyloidosis: Methodology and correlation with cardiac functional parameters
por: Watanabe, Satoru, et al.
Publicado: (2021)

Pitfalls of the Semi-Quantitative Analyzing (99m)Tc-Pyrophosphate Planar Images for Diagnosing Transthyretin Cardiac Amyloidosis: A Possible Solution
por: Zhu, Yuankai, et al.
Publicado: (2022)

Very late perforation by a Riata implantable cardioverter‐defibrillator lead—A case report
por: Nozoe, Masatsugu, et al.
Publicado: (2018)

Successful percutaneous retrieval of a micra transcatheter pacing system at 8 weeks after implantation
por: Nozoe, Masatsugu, et al.
Publicado: (2018)

Assessment of cardiac amyloidosis with (99m)Tc-pyrophosphate (PYP) quantitative SPECT
por: Ren, Chao, et al.
Publicado: (2021)

Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosis
por: Rauf, Muhammad Umaid, et al.
Publicado: (2023)

Incidentally detected cardiac amyloidosis on (99m)Tc-MDP bone scintigraphy
por: Fathala, Ahmed
Publicado: (2020)

Grade 3 myocardial uptake in (99m)technetium-pyrophosphate scintigraphy in light chain cardiac amyloidosis
por: Okada, Atsushi, et al.
Publicado: (2021)

Usefulness of 99mTc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis
por: Galat, Arnault, et al.
Publicado: (2015)

(99m)Tc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis
por: Quarta, Candida Cristina, et al.
Publicado: (2021)

Diagnostic Efficacy of Cardiac Scintigraphy with (99m)Tc-Pyrophosphate for Latent Myocardial Inflammation in Patients with Atrial Fibrillation
por: Ilyushenkova, Julia, et al.
Publicado: (2020)

Conversion of (99m)technetium-pyrophosphate scintigraphy in a patient with hereditary ATTR amyloidosis: importance of repeat scanning
por: Hussain, Muzna, et al.
Publicado: (2020)

Direct comparison of diagnostic and clinical values between Tc-99 m DPD and Tc-99 m PYP scintigraphy in patients with cardiac amyloidosis
por: Park, Yong-Jin, et al.
Publicado: (2023)

(99m)Tc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis
por: Pilebro, Björn, et al.
Publicado: (2016)

Cardiac transthyretin amyloidosis (99m)Tc-DPD SPECT correlates with strain echocardiography and biomarkers
por: Löfbacka, Viktor, et al.
Publicado: (2020)

False positive technetium-99m pyrophosphate scintigraphy in a patient with cardiac amyloidosis light chain: Case report
por: Zeng, Yu, et al.
Publicado: (2021)

Corrigendum to: A new therapy for Transthyretin amyloidosis, no longer an orphan condition
Publicado: (2021)

Inappropriate subcutaneous implantable cardioverter defibrillator shock due to incomplete sealing of the seal plug: a case report
por: Ajimi, Tsuneki, et al.
Publicado: (2022)

Isolated atrial amyloidosis suspected by electrophysiological voltage mapping and diagnosed by (99m)Tc‐DPD scintigraphy
por: Doreen, Schöppenthau, et al.
Publicado: (2020)

Enhanced quantitative method for the diagnosis of grade 1 cardiac amyloidosis in (99)mTc-DPD scintigraphy
por: Mallón Araujo, María del Carmen, et al.
Publicado: (2022)

Negative bone scintigraphy in wild-type transthyretin cardiac amyloidosis
por: Martini, Nicolò, et al.
Publicado: (2020)

Potential diagnostic pitfalls of bone scintigraphy in transthyretin-related amyloidosis
por: Meristoudis, Georgios, et al.
Publicado: (2020)

(99m)Technetium‐pyrophosphate bone scan: A potential biomarker for the burden of transthyretin amyloidosis in skeletal muscle: A preliminary study
por: Wlodarski, Richard, et al.
Publicado: (2022)

Successful Catheter Ablation for Multiple Atrial Arrhythmias in a Patient with Situs Inversus Totalis
por: Tsujioka, Satoshi, et al.
Publicado: (2020)

Effects of Patient Background and Treatment Strategy on Clinical Outcomes After Coronary Intervention for Calcified Nodule Lesions
por: Nozoe, Masatsugu, et al.
Publicado: (2021)

Prognostic significance of incidental suspected transthyretin amyloidosis on routine bone scintigraphy
por: Suomalainen, Olli, et al.
Publicado: (2020)

The diagnostic value of 99m-Tc GSA scintigraphy for liver function and remnant liver volume in hepatic surgery: a retrospective observational cohort study in 27 patients
por: Chiba, Naokazu, et al.
Publicado: (2018)

1-hour versus 3-hour (99m)Tc-PYP imaging to evaluate suspected cardiac transthyretin amyloidosis
por: Nichols, Kenneth J., et al.
Publicado: (2023)

(99m)Tc-DPD scintigraphy and SPECT/CT in patients with AL and ATTR type amyloidosis: Potential clinical implications
por: Lee, Joohee, et al.
Publicado: (2020)

Convolutional neural networks for detection of transthyretin amyloidosis in 2D scintigraphy images
por: Halme, Hanna-Leena, et al.
Publicado: (2022)

Scintigraphic Imaging of Inflammation in the Aortic Wall Using (99m)Tc-Pyrophosphate
por: Ilyushenkova, J.N., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7in7div8s1lq7ngu7nrpjj2v1o